stockrow
Friday 6 November 2026
Export FMS’s income statement to Excel — free account
Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
23.32
0.34
−1.44%
Follow FMS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
11.96 | 11.72 | 11.87 | 12.47 |
+8 more quarters Free account |
P/S ratio |
0.52 | 0.54 | 0.55 | 0.62 | |
P/FCF ratio |
5.80 | 5.91 | 6.08 | 6.88 | |
P/Operating CF |
13.00 | 12.16 | 46.77 | 12.96 | |
P/B ratio |
0.74 | 0.77 | 0.75 | 0.86 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.83 | 0.85 | 0.86 | 0.89 | |
EV/EBITDA |
4.90 | 4.94 | 4.99 | 5.27 | |
EV/Operating CF |
5.78 | 5.95 | 6.18 | 6.54 | |
EV/FCF |
9.23 | 9.38 | 9.47 | 9.83 | |
Quick Ratio |
0.62 | 0.68 | 0.79 | 0.84 | |
Current Ratio |
0.99 | 1.07 | 1.20 | 1.26 | |
Net Debt/EBITDA |
7.49 | 7.41 | 7.89 | 5.62 | |
Debt/Assets |
23.97% | 24.18% | 23.95% | 23.56% | |
Debt/Equity |
0.55 | 0.56 | 0.53 | 0.51 | |
Asset Turnover |
0.63 | 0.63 | 0.63 | 0.62 | |
Operating CF/Net income |
4.92 | 3.93 | 1.93 | 2.89 | |
Capex/Depreciation |
(0.54) | (0.65) | (0.40) | (1.20) | |
Interest Coverage |
3.94 | 4.78 | 3.07 | 5.87 | |
Research and Development Expense of Revenue |
0.84% | 0.82% | 0.83% | 0.77% | |
Selling, General and Administrative Expense of Revenue |
15.06% | 15.14% | 16.24% | 15.50% | |
Intangible Assets out of Total Assets |
0.49 | 0.49 | 0.48 | 0.48 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.96) | (0.96) | (0.86) | (0.72) | |
Graham Number |
35.61 | 35.67 | 35.93 | 34.53 | |
Earnings Yield |
8.36% | 8.54% | 8.42% | 8.02% | |
Free Cash Flow Yield |
17.25% | 16.91% | 16.44% | 14.54% | |
Revenue per Share |
10.80 | 10.53 | 9.81 | 10.16 | |
Operating CF per Share |
1.72 | 1.86 | 0.48 | 1.84 | |
Capex per Share |
(0.50) | (0.51) | (0.40) | (0.78) | |
Free Cash Flow per Share |
1.22 | 1.35 | 0.08 | 1.06 | |
Cash per Share |
3.25 | 3.14 | 3.45 | 3.97 | |
Shareholders Equity per Share |
30.11 | 29.30 | 30.20 | 27.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.11 | 29.30 | 30.20 | 27.75 | |
Free Cash Flow |
641.30 | 726.32 | 46.70 | 615.48 | |
Working Capital |
(75.50) | 595.00 | 1,613.32 | 1,870.54 | |
Capital Expenditures |
(263.97) | (272.21) | (218.85) | (454.85) | |
Net Current Asset Value |
(11,339.47) | (11,711.52) | (10,714.94) | (9,980.22) | |
EV/EBIT |
9.38 | 9.12 | 9.42 | 9.59 | |
Capex to Sales |
0.05 | 0.05 | 0.04 | 0.08 | |
Price to Operating Income |
5.89 | 5.75 | 6.05 | 6.71 | |
| Other line items | |||||
Average Receivables |
3,899.46 | 3,848.67 | 4,066.39 | 3,640.01 | |
Average Payables |
1,017.19 | 945.16 | 992.97 | 1,005.24 | |
Average Inventory |
2,608.32 | 2,488.55 | 2,442.65 | 2,329.88 | |
Average Assets |
36,150.93 | 35,953.20 | 35,658.02 | 35,699.22 | |
Average Common Equity |
16,046.20 | 15,998.30 | 16,479.66 | 16,611.34 |
Columns are period end dates · fundamentals updated 5 Nov 2026